Cargando…
Risk Stratification and Clinical Characteristics of Patients with Late Recurrence of Melanoma (>10 Years)
Background: Most patients with high-risk melanomas develop metastasis within the first few years after diagnosis. However, late recurrence of melanoma is seen in patients that metastasize more than 10 years after the primary diagnosis; a metastasis after 15 years is considered an ultra-late recurren...
Autores principales: | Reschke, Robin, Dumann, Konstantin, Ziemer, Mirjana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9000041/ https://www.ncbi.nlm.nih.gov/pubmed/35407631 http://dx.doi.org/10.3390/jcm11072026 |
Ejemplares similares
-
Identifying High-Risk Tumors within AJCC Stage IB–III Melanomas Using a Seven-Marker Immunohistochemical Signature
por: Reschke, Robin, et al.
Publicado: (2021) -
Effective Extracorporeal Photopheresis of Patients with Transplantation Induced Acute Intestinal GvHD and Bronchiolitis Obliterans Syndrome
por: Reschke, Robin, et al.
Publicado: (2022) -
Distinct Immune Signatures Indicative of Treatment Response and Immune-Related Adverse Events in Melanoma Patients under Immune Checkpoint Inhibitor Therapy
por: Reschke, Robin, et al.
Publicado: (2021) -
Case Report: Graft Versus Tumor Effect After Non-Myeloablative Allogeneic Stem-Cell Transplantation in a Patient With Brentuximab-Vedotin Refractory Sezary Syndrome
por: Franke, Georg-Nikolaus, et al.
Publicado: (2021) -
Risk stratification for melanoma
por: Olsen, Catherine M., et al.
Publicado: (2019)